The Alberta Idealized Throat, a new cascade impactor induction port designed to represent conditions in the human throat better than the standard USP/Ph.Eur induction port, will be introduced by Copley Scientific at DDL 21. The new induction port, developed with the University of Alberta, provides data intended to support improved in vivo/in vitro correlations for R&D purposes. Read the company’s press release
Copley Scientific to launch Alberta Throat at DDL 21
published on
Featured event:
Upcoming Events
Sponsored by Intertek,, hosts of
The Inhaled & Nasal Biologics | DNA Forum
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
July 13-July 16: 2026 ISAM Congress, Taipei, Taiwan
September 15-September 18: DDL New Researcher Network Summer Event, London, UK
September 16-September 17: IPAC-RS 2026 Nasal Innovation Forum, Jersey City, NJ, USA
September 24-September 25: Inhaled & Nasal Biologics | DNA Forum, Cambridge, UK
October 14-October 15: Advancing Bioequivalence Frameworks for Inhalation and Nasal Drug Products: Optimizing In Vitro, In Vivo, and In Silico Methods, Rockville, MD, USA
